Pharsight
Ask Pharsight
NEKTAR THERAPEUTICS INDIA PVT LTD PATENTS FACING OPPOSITIONS
Top patents of NEKTAR THERAPEUTICS INDIA PVT LTD facing oppositions at the European Patent Office (EPO)
Activity Alert
Get e-mail alerts for changes to below patents
Patent Number
Grant Date
Patent Title
Expected Expiration Date
Facing Oppositions
Activity Alert
EP3134123B1
17 Feb, 2021
Il-2Rbeta-Selective Agonists In Combination With An Anti-Ctla-4 Antibody Or An An Anti-Pd-1 Antibody
Feb, 2035
1